$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2023 Q1 Form 10-K Financial Statement

#000118518523000301 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.313M $1.463M $5.745M
YoY Change -8.04% 2.7% 6.33%
Cost Of Revenue $295.2K $377.1K $1.109M
YoY Change 24.24% 39.85% 24.37%
Gross Profit $1.017M $1.086M $4.636M
YoY Change -14.49% -5.97% 2.76%
Gross Profit Margin 77.51% 74.23% 80.7%
Selling, General & Admin $925.6K $1.111M $3.936M
YoY Change 0.23% -0.61% -0.26%
% of Gross Profit 90.97% 102.32% 84.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.379K $10.85K $34.00K
YoY Change 123.31% -16.09% -30.46%
% of Gross Profit 0.92% 1.0% 0.73%
Operating Expenses $1.230M $1.122M $5.079M
YoY Change 32.61% 12.47% 27.12%
Operating Profit $82.46K -$36.03K $666.1K
YoY Change -68.54% -122.89% 28.98%
Interest Expense $99.82K $27.20K $27.20K
YoY Change -1913.33% -624.08%
% of Operating Profit 121.06% 4.08%
Other Income/Expense, Net $34.00K $182.4K
YoY Change 233.71% -10.89%
Pretax Income $182.3K -$8.840K $693.3K
YoY Change -30.46% -102.35% -42.03%
Income Tax $51.16K $3.340K $200.4K
% Of Pretax Income 28.07% 28.91%
Net Earnings $131.1K -$12.18K $492.9K
YoY Change -30.46% -103.85% -50.46%
Net Earnings / Revenue 9.99% -0.83% 8.58%
Basic Earnings Per Share $0.01 $0.04
Diluted Earnings Per Share $0.01 $0.00 $0.04
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.84M $10.78M $10.78M
YoY Change 2.89% 6.94% 6.94%
Cash & Equivalents $1.995M $2.036M
Short-Term Investments $8.848M $8.748M $8.748M
Other Short-Term Assets $170.2K $175.4K $175.4K
YoY Change 60.07% 63.83% 63.83%
Inventory
Prepaid Expenses $170.2K $175.4K
Receivables $997.7K $935.0K $935.0K
Other Receivables $3.000K $3.000K $3.000K
Total Short-Term Assets $12.01M $11.90M $11.90M
YoY Change 4.42% 6.78% 6.78%
LONG-TERM ASSETS
Property, Plant & Equipment $88.24K $97.41K $147.5K
YoY Change -6.6% 5.26% -9.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $6.602K $6.600K
YoY Change -78.71% -75.35% -75.36%
Total Long-Term Assets $136.5K $154.1K $154.2K
YoY Change 6.79% -18.74% -18.74%
TOTAL ASSETS
Total Short-Term Assets $12.01M $11.90M $11.90M
Total Long-Term Assets $136.5K $154.1K $154.2K
Total Assets $12.15M $12.05M $12.05M
YoY Change 4.44% 6.35% 6.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $227.3K $263.0K $275.5K
YoY Change 267.6% 485.81% 513.56%
Accrued Expenses $287.6K $332.6K $356.1K
YoY Change -21.55% 5.41% -3.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $676.0K $708.9K $708.9K
YoY Change 10.2% 41.4% 41.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.52K $10.52K $10.52K
YoY Change
Total Long-Term Liabilities $10.52K $10.52K $10.52K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $676.0K $708.9K $708.9K
Total Long-Term Liabilities $10.52K $10.52K $10.52K
Total Liabilities $702.2K $735.1K $735.1K
YoY Change 13.15% 44.57% 44.57%
SHAREHOLDERS EQUITY
Retained Earnings $11.02M $10.89M
YoY Change 4.74%
Common Stock $12.80K $12.80K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.45M $11.32M $11.32M
YoY Change
Total Liabilities & Shareholders Equity $12.15M $12.05M $12.05M
YoY Change 4.44% 6.35% 6.35%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $131.1K -$12.18K $492.9K
YoY Change -30.46% -103.85% -50.46%
Depreciation, Depletion And Amortization $9.379K $10.85K $34.00K
YoY Change 123.31% -16.09% -30.46%
Cash From Operating Activities -$41.38K $138.9K $711.2K
YoY Change -109.01% -318.44% 84.07%
INVESTING ACTIVITIES
Capital Expenditures $209.00 $21.25K $38.87K
YoY Change -103.41% -443.85% -311.46%
Acquisitions
YoY Change
Other Investing Activities -$8.721M -$8.721M
YoY Change
Cash From Investing Activities -$209.00 -$8.743M -$8.760M
YoY Change -96.59% 141365.37% 47561.46%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00 $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$41.38K 138.9K $711.2K
Cash From Investing Activities -$209.00 -8.743M -$8.760M
Cash From Financing Activities $0.00 0.000 $0.00
Net Change In Cash -$41.59K -8.604M -$8.049M
YoY Change -109.18% 12229.65% -1471.41%
FREE CASH FLOW
Cash From Operating Activities -$41.38K $138.9K $711.2K
Capital Expenditures $209.00 $21.25K $38.87K
Free Cash Flow -$41.59K $117.7K $672.4K
YoY Change -108.93% -304.95% 66.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-50009
CY2022 dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2022 dei City Area Code
CityAreaCode
949
CY2022 dei Local Phone Number
LocalPhoneNumber
721-8272
CY2022 dei Security12g Title
Security12gTitle
$.001 par value, common voting shares
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
4275100 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2022 dei Auditor Firm
AuditorFirmId
6117
CY2022 dei Auditor Name
AuditorName
Pinnacle Accountancy Group of Utah
CY2022 dei Auditor Location
AuditorLocation
Farmington, Utah
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036432 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10085372 usd
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8748435 usd
CY2021Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7807 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23083 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
934990 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
927990 usd
CY2022Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
0 usd
CY2021Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
10055 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
19779 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2021Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175355 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
96977 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11898212 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11143173 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256500 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
526249 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
226323 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
0 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9556 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
762128 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669592 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97405 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92536 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70368 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26788 usd
CY2022Q4 us-gaap Assets
Assets
12052356 usd
CY2021Q4 us-gaap Assets
Assets
11332865 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263022 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44899 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
315495 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3132 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
37000 usd
CY2021Q4 us-gaap Loans Payable
LoansPayable
37000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70368 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
708869 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
501306 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7154 usd
CY2022Q4 us-gaap Liabilities
Liabilities
735065 usd
CY2021Q4 us-gaap Liabilities
Liabilities
508460 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10888418 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10395532 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12052356 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11332865 usd
CY2022 us-gaap Revenues
Revenues
5744957 usd
CY2021 us-gaap Revenues
Revenues
5403110 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48887 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-626 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15656 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
227406 usd
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
237582 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2689842 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2740806 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
314013 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
293936 usd
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
315919 usd
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
321690 usd
CY2022 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
610277 usd
CY2021 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
364951 usd
CY2022 us-gaap Other Expenses
OtherExpenses
182437 usd
CY2021 us-gaap Other Expenses
OtherExpenses
204725 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
705567 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
658402 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5078833 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
4886635 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
666124 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
516475 usd
CY2022 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
0 usd
CY2021 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
684785 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
27199 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5185 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
27199 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
679600 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
693323 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1196075 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
201055 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
995020 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9829385 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
995020 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
492886 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
995020 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48887 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-626 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15656 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
679600 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
27125 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6374 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-119444 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
19779 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
10055 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20186 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
78378 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14478 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-8525 usd
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
12259 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
218123 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35235 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17056 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40343 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3132 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-61828 usd
CY2022 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0 usd
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-2725 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
711237 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
386391 usd
CY2022 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
8721310 usd
CY2021 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38867 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18376 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8760177 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18376 usd
CY2022 us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
CY2021 us-gaap Proceeds From Loans
ProceedsFromLoans
218900 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218900 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8048940 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
586915 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9498457 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2021 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
170000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
294000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
52563 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8721310 usd
CY2022Q4 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
27125 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="text-decoration:underline">Concentrations of Credit Risk</span><p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risks consist of cash and cash equivalents. The Company places its cash and cash equivalents at well-known, quality financial institutions. At times, such cash and investments may be in excess of the FDIC insurance limit. In December 2022, the Company purchased $8,721,310 of U.S. Treasury bills, which will mature on June 8, 2023. As of December 31, 2022 the Company held $2,036,432 in cash, which we believe is enough to cover operating expenses until the bills mature and limits our exposure of holding such cash in excess of the FDIC insurance limit.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8721310 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2036432 usd
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
16000 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
995020 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
995020 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<span style="text-decoration:underline">Use of Estimates</span><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in these audited consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates include the values assigned to the allowance for doubtful accounts and accruals for income taxes.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2020Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
four-shares-for-one-share
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000 shares
CY2018Q2 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
20,000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
37000 usd
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
37000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
23083 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669592 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48887 usd
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
50137 usd
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022 us-gaap Property Plant And Equipment Cost Capitalization
PropertyPlantAndEquipmentCostCapitalization
$1,000
CY2022 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
762128 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
201055 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
127240 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
101118 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
64672 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
112196 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6400 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-9304 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2125 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2955 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
201055 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 usd
CY2022Q4 pfho Net Deferred Tax Asset
NetDeferredTaxAsset
-15679 usd
CY2021Q4 pfho Net Deferred Tax Asset
NetDeferredTaxAsset
-7154 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
138683 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
251176 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
46045 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
79789 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
12070 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
10063 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-143805 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3639 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3832 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The years 2019, 2020, 2021 and 2022 are still open for examination by the Internal Revenue Service
CY2015Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P79M
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
9439 sqft
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
320 sqft
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
52563 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
105292 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0575 pure
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70368 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70368 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
50137 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
70368 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
41898 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10665 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
52563 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2426 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
50137 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
105292 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
279385 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99943 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
115744 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
151150 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
154774 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
22960 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
815 usd
CY2022Q4 pfho Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
42426 usd
CY2021Q4 pfho Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
26372 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
12472 usd
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
12989 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3600 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4801 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
315495 usd
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000 shares
CY2021Q1 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
460700 usd
CY2021Q4 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
218900 usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-23-000301-index-headers.html Edgar Link pending
0001185185-23-000301-index.html Edgar Link pending
0001185185-23-000301.txt Edgar Link pending
0001185185-23-000301-xbrl.zip Edgar Link pending
ex_494313.htm Edgar Link pending
ex_494314.htm Edgar Link pending
ex_494315.htm Edgar Link pending
ex_494316.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20221231_10k.htm Edgar Link pending
pfho-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
pfho-20221231_def.xml Edgar Link unprocessable
pfho-20221231_pre.xml Edgar Link unprocessable
pfho-20221231_lab.xml Edgar Link unprocessable
pacifichco20221231_10k_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pfho-20221231_cal.xml Edgar Link unprocessable